在与年龄相关的黄斑变性中补充系统调节:导航失败,构建未来的成功
Aliénor Vienne-Jumeau1, Elodie Bousquet2, Francine Behar-Cohen3
1Centre hospitalier national d'ophtalmologie des Quinze-Vingts, Paris, France; Ophtalmopôle, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
Current opinion in immunology
|July 29, 2025
概括
针对补体系统的与年龄相关的黄斑变性 (AMD) 治疗减缓了地理缩,但没有改善视力. 未来的疗法需要更早的干预和精确医学,以获得更好的AMD治疗结果.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是老年人不可逆转的视力丧失的主要原因.
- 补充系统的调节失调与AMD的发展和进展有关.
- 目前的补充抑制疗法已被批准用于地理缩,这是AMD的干燥形式.
研究的目的:
- 审查AMD补充向治疗的现状.
- 确定AMD治疗的挑战和未来方向.
主要方法:
- 在AMD中补充系统参与的文献综述.
- 分析当前补充抑制疗法的有效性和局限性.
- 讨论新兴的治疗策略和生物标志物.
主要成果:
- 补充抑制剂适度减缓地理缩病变的生长.
- 目前的治疗方法并不能改善视觉功能.
- 显著的挑战包括干预时间,交付,安全,生物标志物和反应变化.
结论:
- 补充调制是一种有希望但复杂的AMD治疗策略.
- 未来的进步需要更早的干预,精准医学与遗传和成像生物标志物.
- 探索组合或基因疗法对于改善AMD治疗结果至关重要.
相关概念视频
01:27Complement System
2.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.7K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K